Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Oct 02, 2026
Taylor Devices (TAYD): Record Backlog Supports Defense Growth Amid Structural Challenges

Taylor Devices (TAYD): Record Backlog Supports Defense Growth Amid Structural Challenges

Key Takeaways

  • Record backlog as a growth catalyst: A firm order backlog of roughly $55.2 million, heavily weighted toward aerospace and defense, offers multi-quarter revenue visibility as management works to convert orders into recognized sales.
  • Defense-driven mix shift: Aerospace and defense now dominates the backlog, positioning Taylor Devices to benefit from rising global defense spending and rearmament trends.
  • Structural market headwinds: The seismic and structural business remains pressured by higher interest rates and unfavorable foreign exchange (FX) rates, which could delay commercial construction demand.
  • Balance-sheet strength: A debt-free profile with substantial cash and short-term investments supports self-funded growth and capacity expansion without reliance on borrowing.
  • Analyst sentiment: Consensus price targets have trended higher, with recent activity reflecting a mix of upgrades and cautious downgrades rather than uniform optimism.
  • Key risks: Customer concentration, uneven project timing, margin pressure from new product development, and dependence on government contracts could alter the outlook.

Company Positioning and Competitive Landscape

Taylor Devices, Inc. (TAYD) is a North Tonawanda, New York-based manufacturer of shock absorption, rate control, and energy storage devices. Its portfolio spans seismic dampers, compact shock absorbers (Fluidicshoks), crane and industrial buffers, vibration dampers, machined springs, and custom actuators, serving three end markets: aerospace and defense, structural, and industrial.

The company's medium-term positioning is increasingly defined by its pivot toward aerospace and defense. That segment now represents the overwhelming majority of the order backlog and is becoming the dominant revenue driver, supported by mission-critical applications with high barriers to entry and rigorous qualification standards. This concentration provides a degree of pricing resilience and demand visibility, but it also raises sensitivity to federal procurement cycles and program timing. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

On the structural side, Taylor Devices holds a recognized niche in seismic damping and retrofit solutions, a market with long-term tailwinds tied to infrastructure resilience and building-code mandates. However, near-term demand has softened as elevated borrowing costs weigh on commercial construction. The company's vertically integrated machining capability and a planned rapid-prototyping development lab are intended to improve agility and shorten product-development cycles, reinforcing its competitive position across all three segments.

Key Catalysts to Monitor

Several forward-looking catalysts could shape investor sentiment toward Taylor Devices in the coming quarters. The most significant is the execution against its record backlog. Management has indicated it expects to recognize the majority of the remaining backlog during the fiscal year ending May 31, 2027, making the pace and timing of revenue conversion a central watch item. A faster-than-expected conversion could reaccelerate sales growth after a period of softer quarterly results.

Product development and facility investment represent a second catalyst. The company is building a state-of-the-art development lab for rapid prototyping, and it has committed to additional capital expenditures for new manufacturing and testing equipment. These investments, alongside rising research and development (R&D) spending, could support new aerospace and defense program wins and broaden the addressable market.

Analyst activity has also become more dynamic. Recent rating actions reflect a mixed tone: one firm upgraded the stock and raised its price target from $67 to $70, while another shifted from a buy to a hold rating at a $70 target earlier in the year. The consensus twelve-month price target has risen to approximately $70, and longer-term earnings estimates have trended modestly higher, suggesting expectations for a rebound in fiscal 2027 and 2028. Investors will likely monitor whether upgrades outpace downgrades as backlog conversion gains visibility.

Industry and Macroeconomic Context

Taylor Devices' trajectory is closely tied to two contrasting macro environments. In aerospace and defense, elevated geopolitical tensions and rising global defense budgets create a favorable demand backdrop for shock isolation, energy damping, and motion-control components used in mission-critical systems. This tailwind is structural in nature and could persist even if broader economic growth moderates. From what I see, the defense exposure stands out as a durable advantage here.

By contrast, the structural and industrial businesses are more cyclical. Higher interest rates raise financing costs for commercial real estate and infrastructure projects, while unfavorable foreign exchange rates pressure international sales, particularly in Asia. These forces have contributed to softer structural demand and a shift toward domestic revenue concentration.

Inflation dynamics also matter for a company that recognizes a meaningful portion of revenue on fixed-price long-term contracts. Rising labor, material, and overhead costs can compress margins if estimates prove conservative, while inventory obsolescence risk remains elevated in end markets marked by rapid technological change. The interplay between defense-led resilience and cyclical commercial softness will likely define the near-term earnings profile.

Outlook Through 2026 and Longer-Term Themes

Looking across the remainder of 2026 and into 2027, the central question for Taylor Devices is whether record backlog can translate into sustained revenue growth and margin recovery. Consensus estimates imply a meaningful step-up in sales and earnings per share (EPS) over the next two fiscal years, a reflection of expectations that delayed orders will begin converting into recognized revenue.

Longer term, several structural themes warrant attention. First, the growing weight of aerospace and defense in the revenue mix positions the company to participate in global rearmament and defense-modernization spending, though it also concentrates exposure to government contract cycles and customer concentration risk. Second, the seismic and structural business retains a durable long-term growth case tied to building retrofits, resilience mandates, and aging infrastructure, once interest-rate pressures ease.

Margin sustainability will hinge on the company's ability to manage fixed-price contract costs, absorb rising R&D spending, and control inventory obsolescence. Capital allocation remains conservative, with a debt-free balance sheet and ample liquidity providing optionality for capacity expansion, product development, or strategic investments. Competitive and technological disruption, as well as any shift in federal defense spending priorities, represent the most significant long-term risks to the outlook. Consensus price targets, which have moved higher into the $70 range, reflect external analyst expectations rather than any forecast by this article.

Using AI Tools to Track Trends

In my analysis of names like Taylor Devices, I often turn to Tickeron’s AI Trend Prediction Engine to get a data-driven view of potential price movements over the coming weeks or months. It helps surface bullish, bearish, or sideways scenarios based on historical patterns and current signals, which complements the fundamental work on backlog conversion and sector tailwinds. This kind of tool adds another layer when evaluating timing around defense-driven growth and macro headwinds.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TAYD

TAYD in +2.37% Uptrend, advancing for three consecutive days on September 24, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where TAYD advanced for three days, in 201 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on TAYD as a result. In 69 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.

The Aroon Indicator entered an Uptrend today. In 165 of 215 cases where TAYD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

Bearish Trend Analysis

The 10-day RSI Indicator for TAYD moved out of overbought territory on September 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 32 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 78%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 41 of 63 cases where TAYD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 65%.

The Moving Average Convergence Divergence Histogram (MACD) for TAYD turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 33 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TAYD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

TAYD broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. TAYD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 53 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.884) is normal, around the industry mean (5.342). P/E Ratio (24.863) is within average values for comparable stocks, (66.065). Projected Growth (PEG Ratio) (0.360) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.014) among similar stocks. P/S Ratio (4.704) is also within normal values, averaging (186.943).

Notable companies

The most notable companies in this group are Illinois Tool Works (NYSE:ITW), Ingersoll Rand (NYSE:IR), Generac Holdings (NYSE:GNRC).

Industry description

The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.

Market Cap

The average market capitalization across the Industrial Machinery Industry is 15.66B. The market cap for tickers in the group ranges from 3.71K to 252.96B. GEV holds the highest valuation in this group at 252.96B. The lowest valued company is SPEC at 3.71K.

High and low price notable news

The average weekly price growth across all stocks in the Industrial Machinery Industry was -2%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -3%. INLF experienced the highest price growth at 38%, while OPTT experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Industrial Machinery Industry was -43%. For the same stocks of the Industry, the average monthly volume growth was 9% and the average quarterly volume growth was 23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 54
Price Growth Rating: 60
SMR Rating: 70
Profit Risk Rating: 75
Seasonality Score: 31 (-100 ... +100)
View a ticker or compare two or three
TAYD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of shock absorption, rate control and energy storage devices

Industry IndustrialMachinery

Industry
Industrial Machinery
Address
90 Taylor Drive
Phone
+1 716 694-0800
Employees
135
Web
https://www.taylordevices.com
Interact to see
Advertisement
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.
AA shares are surging approximately +11.79% intraday on Monday, March 30, 2026, trading around $64.55 versus Friday's close of approximately $57.74. The primary catalyst is a supply shock in the global aluminum market: two major Middle Eastern aluminum producers — including Bahrain's Aluminium Bahrain (ALBA) — reported being struck by Iranian attacks, raising fears of significant output disruptions.
BSX shares are falling approximately 7.00% during Monday's session, trading near $64.33, down from Friday's close of $69.17. Primary catalyst: A "sell the news" reaction to Saturday's CHAMPION-AF clinical trial data for the WATCHMAN FLX™ device — results met all endpoints but contained meaningful caveats that are spooking investors.
Shares of CIEN are declining approximately -7.00% in Monday's session, with the stock trading near $369.68, versus a prior close of $397.50 on Friday, March 27, 2026. The primary catalyst is a broad, tariff-driven market sell-off as the Trump administration's escalating trade posture rattles investor sentiment across the technology and networking sectors heading into quarter-end.
Bloom Energy (BE) shares are trading down approximately 8.00% intraday on Monday, March 30, 2026, falling from a prior close of $133.24 to around $122.58, extending a turbulent stretch for the stock. The decline is driven by a confluence of broad macro selling pressure, renewed concerns around AI data center demand durability, and investor uncertainty following a CFO transition announced on Friday.
AAOI shares are trading down approximately 10.00% intraday on Monday, March 30, falling from a prior close of $98.21 to around $88.39. A broad-based market sell-off fueled by renewed tariff fears and macro uncertainty is putting acute pressure on technology and semiconductor-linked stocks.
In recent trading sessions, I've been watching the GraniteShares 2x Long DELL Daily ETF (DLLL) closely, as it shows heightened volatility that mirrors amplified movements in its underlying asset, Dell Technologies (DELL). From what I see, the ETF's performance reflects robust demand for AI-optimized servers and infrastructure solutions, propelling gains during periods of positive sentiment around DELL's earnings and strategic positioning. Recent weeks have seen sharp intraday swings, underscoring the leveraged nature of DLLL, which seeks 2x daily exposure before fees. Trading volumes have surged alongside broader interest in AI-related plays, though the ETF remains suitable primarily for short-term tactical positioning amid ongoing market cycles in technology hardware.
Planet Labs PBC (PL) shares fell 4.75% in the most recent completed session, closing at $30.86 versus a prior close of $32.40. Premarket indications today show PL down further, with quotes around $30.53–31.35, roughly 1–2% below Friday’s close, after having traded down as much as about 9% intraday last week.
SUNation Energy Inc. (SUNE) is indicated down about 19% in Monday’s premarket session after previously closing just under the mid‑$2 range in recent trading. The drop follows an exceptionally volatile March in which SUNE shares repeatedly surged on technical breakouts and debt‑restructuring news, including single‑day gains of 19–26%.
Micron Technology, Inc. (MU) fell 5.71% in the most recent completed session, dropping from a prior close of $357.21 to $336.84. The decline extends a pullback that began after MU’s post‑earnings surge in mid‑March, when the shares traded near a 52‑week high above $470 before sliding roughly 24–30% over subsequent sessions.
Karman Holdings Inc. (KRMN) fell 5.38% in the most recent completed session, closing at $84.07 after trading between $83.43 and $88.98. The pullback comes after a powerful multi‑month rally that saw the stock climb from a 52‑week low of about $25.02 to a high of $118.38, leaving it vulnerable to profit‑taking and valuation compression.
Lumentum Holdings Inc. (LITE) shares fell 4.93% in the most recent completed session, sliding from a prior close of $702.75 to $668.10. The drop comes after a massive AI-driven rally that pushed LITE up more than 1,000% over the past year and more than doubled year to date, leaving valuations stretched and vulnerable to profit‑taking.